Marinus Pharmaceuticals reported $82M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 425.69M 9.16M
Amgen AMGN:US USD 3.65B 1.23B
Aptinyx Inc APTX:US USD 48.79M 13.31M
Biogen BIIB:US USD 12.78B 903M
Eisai 4523:JP JPY 828.13B 23.58B
Enanta Pharmaceuticals ENTA:US USD 321.33M 16.69M
Esperion Therapeutics ESPR:US USD -294100000 2.4M
Gilead Sciences GILD:US USD 21.06B 821M
Intercept Pharmaceuticals ICPT:US USD 107.68M 477.51M
Intra Cellular Therapies ITCI:US USD 685.42M 36.78M
Marinus Pharmaceuticals MRNS:US USD 82M 77.2M
Minerva Neurosciences NERV:US USD -14246000 5.86M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Ptc Therapeutics PTCT:US USD -226904000 44.69M
Regeneron Pharmaceuticals REGN:US USD 21.44B 751M
Sarepta Therapeutics SRPT:US USD 430.84M 295.62M
Supernus Pharmaceuticals SUPN:US USD 852.8M 11.36M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B
YTE INCY:US USD 4.23B 141.59M